CytoRecovery
PrivateLast Round
Accelerator
Jun 3, 2024
Total Funding Raised
$1.55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CytoRecovery is a biotechnology company that develops microfluidic technology designed to recover biological cells from samples.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoRecovery Comparables
Compare CytoRecovery with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| On-chip Biotechnologies Co., Ltd. | 85% | |
| LevitasBio | 83% | |
| NanoCellect Biomedical | 81% | |
CytoRecovery Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 3, 2024 | ||||
| Grant | Feb 9, 2023 | ||||
| Seed | Dec 1, 2022 | ||||
| Convertible Debt | Apr 22, 2019 | ||||
| Pre Seed | Oct 19, 2018 |
CytoRecovery Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Virginia LVG Seed Fund | Seed |
| Common Wealth Angels | Convertible Debt, Seed |
| Virginia Innovation Partnership Corporation | Convertible Debt |
| The Launch Place | Pre Seed, Seed |
| BioTools Innovator | Accelerator |
| Bloomfield Partners | Convertible Debt, Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 31% MoM, from 1.5K to 2K.
- Jul 20, 2026
Open roles increased from 0 to 4, representing 80% of headcount.
CytoRecovery Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CytoRecovery's valuation, stock price, and market status.